BACKGROUND: Fibrogenesis during idiopathic pulmonary fibrosis (IPF) is strongly associated with abnormal vascular remodeling. Respective abundance of circulating endothelial cells (CEC) and endothelial progenitor cells (EPC) might reflect the balance between vascular injury and repair and potentially serve as biomarkers of the disease. OBJECTIVES AND METHODS: We postulated that CEC and EPC subtypes might be differently modulated in IPF. Sixty-four consecutive patients with newly diagnosed IPF were prospectively enrolled and compared to thirteen healthy volunteers. CEC were counted with immunomagnetic CD146-coated beads; progenitors CD34+45(dim)/CD34+133+/CD34+KDR+were assessed through flow cytometry and EPC (colony-forming-units-Endothelial Cells, CFU-EC, and endothelial colonies forming cells, ECFC) were quantified by cell culture assays. RESULTS: IPF patients were characterized by a marked increase in CEC associated to an EPC defect: both CD34(+)KDR(+) cells and CFU-EC were decreased versus controls. Moreover, in IPF subjects with a low diffusing capacity of the lung for carbon monoxide (DL(CO)) < 40 %, CFU-EC and ECFC were higher compared to those with DL(CO) > 40 %. Finally, ECFC were negatively correlated with DL(CO). During an 18 month follow up, CEC levels increased in patients with exacerbation, including those who died during follow up. Finally, ECFC from patients with exacerbation proliferative potential was strongly increased. CONCLUSION: IPF is basically associated with both a vascular injury and a repair defect. This study highlights an adaptative process of EPC mobilization in the most severe forms of IPF, that could reflect enhanced homing to the pulmonary vasculature, which clinical consequences remain to be determined.
BACKGROUND: Fibrogenesis during idiopathic pulmonary fibrosis (IPF) is strongly associated with abnormal vascular remodeling. Respective abundance of circulating endothelial cells (CEC) and endothelial progenitor cells (EPC) might reflect the balance between vascular injury and repair and potentially serve as biomarkers of the disease. OBJECTIVES AND METHODS: We postulated that CEC and EPC subtypes might be differently modulated in IPF. Sixty-four consecutive patients with newly diagnosed IPF were prospectively enrolled and compared to thirteen healthy volunteers. CEC were counted with immunomagnetic CD146-coated beads; progenitors CD34+45(dim)/CD34+133+/CD34+KDR+were assessed through flow cytometry and EPC (colony-forming-units-Endothelial Cells, CFU-EC, and endothelial colonies forming cells, ECFC) were quantified by cell culture assays. RESULTS: IPF patients were characterized by a marked increase in CEC associated to an EPC defect: both CD34(+)KDR(+) cells and CFU-EC were decreased versus controls. Moreover, in IPF subjects with a low diffusing capacity of the lung for carbon monoxide (DL(CO)) < 40 %, CFU-EC and ECFC were higher compared to those with DL(CO) > 40 %. Finally, ECFC were negatively correlated with DL(CO). During an 18 month follow up, CEC levels increased in patients with exacerbation, including those who died during follow up. Finally, ECFC from patients with exacerbation proliferative potential was strongly increased. CONCLUSION: IPF is basically associated with both a vascular injury and a repair defect. This study highlights an adaptative process of EPC mobilization in the most severe forms of IPF, that could reflect enhanced homing to the pulmonary vasculature, which clinical consequences remain to be determined.
Authors: David M Smadja; Juan M Melero-Martin; Jeroen Eikenboom; Mackenzie Bowman; Florence Sabatier; Anna M Randi Journal: J Thromb Haemost Date: 2019-05-22 Impact factor: 5.824
Authors: Maximilian Ackermann; Yong Ook Kim; Willi L Wagner; Detlef Schuppan; Cristian D Valenzuela; Steven J Mentzer; Sebastian Kreuz; Detlef Stiller; Lutz Wollin; Moritz A Konerding Journal: Angiogenesis Date: 2017-03-10 Impact factor: 9.596
Authors: Elisa Rossi; Sonia Poirault-Chassac; Ivan Bieche; Richard Chocron; Anne Schnitzler; Anna Lokajczyk; Pierre Bourdoncle; Blandine Dizier; Nour C Bacha; Nicolas Gendron; Adeline Blandinieres; Coralie L Guerin; Pascale Gaussem; David M Smadja Journal: Stem Cell Rev Rep Date: 2019-08 Impact factor: 5.739
Authors: Marilyne Levy; Damien Bonnet; Laetitia Mauge; David S Celermajer; Pascale Gaussem; David M Smadja Journal: PLoS One Date: 2013-06-10 Impact factor: 3.240
Authors: Kim H Chan; Philippa J L Simpson; Andy S Yong; Louise L Dunn; Chirapan Chawantanpipat; Chijen Hsu; Young Yu; Anthony C Keech; David S Celermajer; Martin K C Ng Journal: PLoS One Date: 2014-04-15 Impact factor: 3.240